RECRUITING

CEUS for Blunt Abdominal Trauma in Children

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Children with blunt abdominal trauma often get a CT as the first line imaging to evaluate for intra-abdominal organ injury. CT scans have some downsides with regard to radiation exposure, costs, and need for transport. Contrast enhanced ultrasonography has recently shown some promise as a way to detect intra-abdominal organ injury and may be able to replace the need for conventional CT scanning, without the need for ionizing radiation and the ability to be performed at the bedside.

Official Title

Contrast Enhanced Ultrasonography for Blunt Abdominal Trauma Imaging in Children

Quick Facts

Study Start:2018-06-01
Study Completion:2025-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03490929

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:0 Years to 17 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:CHILD
Inclusion CriteriaExclusion Criteria
  1. 1. Hemodynamically stable (defined as not needing massive transfusion protocol and not undergoing an emergent surgical procedure within the next hour)
  2. 2. History of or suspicion for blunt abdominal trauma
  3. 3. Abdominal CT ordered or obtained
  1. 1. History of allergic reaction to Lumason, sulfur hexaflouride, sulfur hexafluoride lipid microsphere components, or other ingredients in Lumason (polyethylene glycol, distearoylphosphatidylcholine (DSPC), dipalmitoylphosphatidylglycerol sodium (DPPG-Na), palmitic acid)
  2. 2. Co-existing penetrating abdominal trauma
  3. 3. Known congenital or acquired heart disease

Contacts and Locations

Study Contact

Aaron E Chen, MD
CONTACT
2674260383
chena2@chop.edu
Rachel Rempell, MD
CONTACT
2155907041
rempellr@chop.edu

Principal Investigator

Aaron E Chen, MD
PRINCIPAL_INVESTIGATOR
Children's Hospital of Philadelphia

Study Locations (Sites)

Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, 19146
United States

Collaborators and Investigators

Sponsor: Children's Hospital of Philadelphia

  • Aaron E Chen, MD, PRINCIPAL_INVESTIGATOR, Children's Hospital of Philadelphia

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2018-06-01
Study Completion Date2025-12-31

Study Record Updates

Study Start Date2018-06-01
Study Completion Date2025-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Trauma Abdomen